Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Trustmark
TRMK
$2.79B
| $18.4M | ﹤0.01% |
528,338
-307,861
| -37% | -$10.8M |
|
2027
Badger Meter
BMI
$3.98B
| $18.4M | ﹤0.01% |
169,077
-6,187
| -4% | -$672K |
|
2028
Coca-Cola Consolidated
COKE
$12.5B
| $18.4M | ﹤0.01% |
359,130
-189,850
| -35% | -$9.08M |
|
2029
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
| $18.4M | ﹤0.01% |
178,811
-2,392
| -1% | -$241K |
|
2030
Choice Hotels
CHH
$4.99B
| $18.3M | ﹤0.01% |
162,881
-162,833
| -50% | -$19.5M |
|
2031
CALL
Dollar General
DG
$28.1B
| $18.3M | ﹤0.01% |
74,200
+58,700
| +379% | +$14.5M |
|
|
DDL
2032
Dingdong
DDL
$490M
| $18.3M | ﹤0.01% |
+4,275,994
| New | +$16.8M |
|
|
PR
2033
Permian Resources
PR
$17B
| $18.2M | ﹤0.01% |
1,939,744
-536,692
| -22% | -$5.14M |
|
2034
Vanguard ESG International Stock ETF
VSGX
$6.66B
| $18.2M | ﹤0.01% |
370,293
+24,166
| +7% | +$1.15M |
|
|
FARO
2035
DELISTED
Faro Technologies
FARO
| $18.2M | ﹤0.01% |
618,716
-19,822
| -3% | -$589K |
|
2036
PUT
Biogen
BIIB
$30.5B
| $18.2M | ﹤0.01% |
65,600
+27,500
| +72% | +$7.77M |
|
2037
Copa Holdings
CPA
$5.8B
| $18.2M | ﹤0.01% |
218,250
-134,299
| -38% | -$10.6M |
|
2038
CALL
Procter & Gamble
PG
$342B
| $18.1M | ﹤0.01% |
119,500
+26,900
| +29% | +$3.77M |
|
2039
M/I Homes
MHO
$3.71B
| $18.1M | ﹤0.01% |
391,834
-224
| -0.1% | -$9.62K |
|
2040
Nutanix
NTNX
$16.3B
| $18.1M | ﹤0.01% |
693,156
+32,649
| +5% | +$891K |
|
2041
MaxLinear
MXL
$6.37B
| $18.1M | ﹤0.01% |
531,724
-27,360
| -5% | -$927K |
|
2042
Kohl's
KSS
$2.09B
| $18M | ﹤0.01% |
714,774
-2,033,423
| -74% | -$57.6M |
|
2043
VanEck Biotech ETF
BBH
$410M
| $18M | ﹤0.01% |
112,880
+12,880
| +13% | +$2.04M |
|
2044
Cirrus Logic
CRUS
$6.23B
| $18M | ﹤0.01% |
241,936
+33,965
| +16% | +$2.44M |
|
2045
CBIZ
CBZ
$2.96B
| $18M | ﹤0.01% |
383,752
+123,779
| +48% | +$5.88M |
|
2046
Stewart Information Services
STC
$2.09B
| $18M | ﹤0.01% |
420,676
-94,587
| -18% | -$3.96M |
|
2047
German American Bancorp
GABC
$1.91B
| $17.9M | ﹤0.01% |
480,055
-16,238
| -3% | -$619K |
|
2048
Virtu Financial
VIRT
$4.91B
| $17.9M | ﹤0.01% |
876,874
-45,451
| -5% | -$987K |
|
2049
Astec Industries
ASTE
$1.02B
| $17.9M | ﹤0.01% |
439,750
-105,737
| -19% | -$4.27M |
|
2050
Zai Lab
ZLAB
$2.36B
| $17.8M | ﹤0.01% |
581,370
+421,639
| +264% | +$13.3M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.